Pharmaceuticals Global Industry Guide – Market Summary, Competitive Analysis and Forecast to 2025

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

– Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

– All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.

– Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.

– The global pharmaceuticals market had total revenues of $1,112.6bn in 2020, representing a compound annual growth rate (CAGR) of 5.6% between 2016 and 2020.

– Given the strong global demand for vaccines to protect citizens and control the spread of COVID-19, it is likely that pharmaceutical companies offering safe and effective therapeutic solutions will generate significant revenues, contributing to market growth.

– The promotion of generic drugs has become increasingly prevalent globally as many governments seek to generate savings amid rising pharmaceutical prices, and this presents a barrier to growth in the market.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2020?

- What will be the size of the global pharmaceuticals market in 2025?

- What factors are affecting the strength of competition in the global pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the global pharmaceuticals market?

Companies mentioned

Sanofi SA

Laboratoires Pierre Fabre SA

Les Laboratoires Servier

F. Hoffmann-La Roche Ltd

Bayer AG

Boehringer Ingelheim GmbH

Menarini Industrie Farmaceutiche Riunite Srl

Recordati S.p.A.

Chiesi Farmaceutici SpA

Daiichi Sankyo Co Ltd

Astellas Pharma Inc.

Takeda Pharmaceutical Company Limited

Mitsubishi Tanabe Pharma Corporation

Aspen Pharmacare Holdings Ltd

Apotex, Inc.

Yangtze River Pharmaceutical Group

Shanghai Pharmaceuticals Holding Co Ltd

Yunnan Baiyao Group Co Ltd

Guangzhou Pharmaceutical Holdings Ltd

Almirall S.A.

Laboratorios Farmaceuticos ROVI, S.A.

Novartis AG

GlaxoSmithKline Plc

Johnson & Johnson

Pfizer Inc.

Merck & Co., Inc.

AstraZeneca PLC

Table of Contents

Table of Contents

1 EXECUTIVE SUMMARY

1.1. Market value

1.2. Market value forecast

1.3. Geography segmentation

1.4. Market share

1.5. Competitive Landscape

2 Introduction

2.1. What is this report about?

2.2. Who is the target reader?

2.3. How to use this report

2.4. Definitions

3 Global Pharmaceuticals

3.1. Market Overview

3.2. Market Data

3.3. Market Segmentation

3.4. Market outlook

3.5. Five forces analysis

4 Macroeconomic Indicators

4.1. Country data

5 Pharmaceuticals in Asia-Pacific

5.1. Market Overview

5.2. Market Data

5.3. Market Segmentation

5.4. Market outlook

5.5. Five forces analysis

6 Pharmaceuticals in Europe

6.1. Market Overview

6.2. Market Data

6.3. Market Segmentation

6.4. Market outlook

6.5. Five forces analysis

6.6. Macroeconomic Indicators

7 Pharmaceuticals in France

7.1. Market Overview

7.2. Market Data

7.3. Market Segmentation

7.4. Market outlook

7.5. Five forces analysis

7.6. Macroeconomic Indicators

8 Pharmaceuticals in Germany

8.1. Market Overview

8.2. Market Data

8.3. Market Segmentation

8.4. Market outlook

8.5. Five forces analysis

8.6. Macroeconomic Indicators

9 Pharmaceuticals in Italy

9.1. Market Overview

9.2. Market Data

9.3. Market Segmentation

9.4. Market outlook

9.5. Five forces analysis

9.6. Macroeconomic Indicators

10 Pharmaceuticals in Japan

10.1. Market Overview

10.2. Market Data

10.3. Market Segmentation

10.4. Market outlook

10.5. Five forces analysis

10.6. Macroeconomic Indicators

11 Pharmaceuticals in Australia

11.1. Market Overview

11.2. Market Data

11.3. Market Segmentation

11.4. Market outlook

11.5. Five forces analysis

11.6. Macroeconomic Indicators

12 Pharmaceuticals in Canada

12.1. Market Overview

12.2. Market Data

12.3. Market Segmentation

12.4. Market outlook

12.5. Five forces analysis

12.6. Macroeconomic Indicators

13 Pharmaceuticals in China

13.1. Market Overview

13.2. Market Data

13.3. Market Segmentation

13.4. Market outlook

13.5. Five forces analysis

13.6. Macroeconomic Indicators

14 Pharmaceuticals in The Netherlands

14.1. Market Overview

14.2. Market Data

14.3. Market Segmentation

14.4. Market outlook

14.5. Five forces analysis

14.6. Macroeconomic Indicators

15 Pharmaceuticals in Spain

15.1. Market Overview

15.2. Market Data

15.3. Market Segmentation

15.4. Market outlook

15.5. Five forces analysis

15.6. Macroeconomic Indicators

16 Pharmaceuticals in The United Kingdom

16.1. Market Overview

16.2. Market Data

16.3. Market Segmentation

16.4. Market outlook

16.5. Five forces analysis

16.6. Macroeconomic Indicators

17 Pharmaceuticals in The United States

17.1. Market Overview

17.2. Market Data

17.3. Market Segmentation

17.4. Market outlook

17.5. Five forces analysis

17.6. Macroeconomic Indicators

18 Company Profiles

18.1. Sanofi SA

18.2. Laboratoires Pierre Fabre SA

18.3. Les Laboratoires Servier

18.4. F. Hoffmann-La Roche Ltd

18.5. Bayer AG

18.6. Boehringer Ingelheim GmbH

18.7. Menarini Industrie Farmaceutiche Riunite Srl

18.8. Recordati S.p.A.

18.9. Chiesi Farmaceutici SpA

18.10. Daiichi Sankyo Co Ltd

18.11. Astellas Pharma Inc.

18.12. Takeda Pharmaceutical Company Limited

18.13. Mitsubishi Tanabe Pharma Corporation

18.14. Aspen Pharmacare Holdings Ltd

18.15. Apotex, Inc.

18.16. Yangtze River Pharmaceutical Group

18.17. Shanghai Pharmaceuticals Holding Co Ltd

18.18. Yunnan Baiyao Group Co Ltd

18.19. Guangzhou Pharmaceutical Holdings Ltd

18.20. Almirall S.A.

18.21. Laboratorios Farmaceuticos ROVI, S.A.

18.22. Novartis AG

18.23. GlaxoSmithKline Plc

18.24. Johnson & Johnson

18.25. Pfizer Inc.

18.26. Merck & Co., Inc.

18.27. AstraZeneca PLC

19 Appendix

19.1. Methodology

19.2. About MarketLine

List of Tables

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2016-20

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2020

Table 3: Global pharmaceuticals market share: % share, by value, 2020

Table 4: Global pharmaceuticals market value forecast: $ billion, 2020-25

Table 5: Global size of population (million), 2016-20

Table 6: Global gdp (constant 2005 prices, $ billion), 2016-20

Table 7: Global gdp (current prices, $ billion), 2016-20

Table 8: Global inflation, 2016-20

Table 9: Global consumer price index (absolute), 2016-20

Table 10: Global exchange rate, 2016-20

Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20

Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2020

Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020

Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25

Table 15: Europe pharmaceuticals market value: $ billion, 2016-20

Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2020

Table 17: Europe pharmaceuticals market share: % share, by value, 2020

Table 18: Europe pharmaceuticals market value forecast: $ billion, 2020-25

Table 19: Europe size of population (million), 2016-20

Table 20: Europe gdp (constant 2005 prices, $ billion), 2016-20

Table 21: Europe gdp (current prices, $ billion), 2016-20

Table 22: Europe inflation, 2016-20

Table 23: Europe consumer price index (absolute), 2016-20

Table 24: Europe exchange rate, 2016-20

Table 25: France pharmaceuticals market value: $ billion, 2016-20

Table 26: France pharmaceuticals market geography segmentation: $ billion, 2020

Table 27: France pharmaceuticals market share: % share, by value, 2020

Table 28: France pharmaceuticals market value forecast: $ billion, 2020-25

Table 29: France size of population (million), 2016-20

Table 30: France gdp (constant 2005 prices, $ billion), 2016-20

Table 31: France gdp (current prices, $ billion), 2016-20

Table 32: France inflation, 2016-20

Table 33: France consumer price index (absolute), 2016-20

Table 34: France exchange rate, 2016-20

Table 35: Germany pharmaceuticals market value: $ billion, 2016-20

Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2020

Table 37: Germany pharmaceuticals market share: % share, by value, 2020

Table 38: Germany pharmaceuticals market value forecast: $ billion, 2020-25

Table 39: Germany size of population (million), 2016-20

Table 40: Germany gdp (constant 2005 prices, $ billion), 2016-20

Table 41: Germany gdp (current prices, $ billion), 2016-20

Table 42: Germany inflation, 2016-20

Table 43: Germany consumer price index (absolute), 2016-20

Table 44: Germany exchange rate, 2016-20

Table 45: Italy pharmaceuticals market value: $ billion, 2016-20

Table 46: Italy pharmaceuticals market geography segmentation: $ billion, 2020

Table 47: Italy pharmaceuticals market share: % share, by value, 2020

Table 48: Italy pharmaceuticals market value forecast: $ billion, 2020-25

Table 49: Italy size of population (million), 2016-20

Table 50: Italy gdp (constant 2005 prices, $ billion), 2016-20

Table 51: Italy gdp (current prices, $ billion), 2016-20

Table 52: Italy inflation, 2016-20

Table 53: Italy consumer price index (absolute), 2016-20

Table 54: Italy exchange rate, 2016-20

Table 55: Japan pharmaceuticals market value: $ billion, 2016-20

Table 56: Japan pharmaceuticals market geography segmentation: $ billion, 2020

Table 57: Japan pharmaceuticals market share: % share, by value, 2020

Table 58: Japan pharmaceuticals market value forecast: $ billion, 2020-25

Table 59: Japan size of population (million), 2016-20

Table 60: Japan gdp (constant 2005 prices, $ billion), 2016-20

Table 61: Japan gdp (current prices, $ billion), 2016-20

Table 62: Japan inflation, 2016-20

Table 63: Japan consumer price index (absolute), 2016-20

Table 64: Japan exchange rate, 2016-20

Table 65: Australia pharmaceuticals market value: $ billion, 2016-20

Table 66: Australia pharmaceuticals market geography segmentation: $ billion, 2020

Table 67: Australia pharmaceuticals market share: % share, by value, 2020

Table 68: Australia pharmaceuticals market value forecast: $ billion, 2020-25

Table 69: Australia size of population (million), 2016-20

Table 70: Australia gdp (constant 2005 prices, $ billion), 2016-20

Table 71: Australia gdp (current prices, $ billion), 2016-20

Table 72: Australia inflation, 2016-20

Table 73: Australia consumer price index (absolute), 2016-20

Table 74: Australia exchange rate, 2016-20

Table 75: Canada pharmaceuticals market value: $ billion, 2016-20

Table 76: Canada pharmaceuticals market geography segmentation: $ billion, 2020

Table 77: Canada pharmaceuticals market share: % share, by value, 2020

Table 78: Canada pharmaceuticals market value forecast: $ billion, 2020-25

Table 79: Canada size of population (million), 2016-20

Table 80: Canada gdp (constant 2005 prices, $ billion), 2016-20

Table 81: Canada gdp (current prices, $ billion), 2016-20

Table 82: Canada inflation, 2016-20

Table 83: Canada consumer price index (absolute), 2016-20

Table 84: Canada exchange rate, 2016-20

Table 85: China pharmaceuticals market value: $ billion, 2016-20

Table 86: China pharmaceuticals market geography segmentation: $ billion, 2020

Table 87: China pharmaceuticals market share: % share, by value, 2020

Table 88: China pharmaceuticals market value forecast: $ billion, 2020-25

Table 89: China size of population (million), 2016-20

Table 90: China gdp (constant 2005 prices, $ billion), 2016-20

Table 91: China gdp (current prices, $ billion), 2016-20

Table 92: China inflation, 2016-20

Table 93: China consumer price index (absolute), 2016-20

Table 94: China exchange rate, 2016-20

Table 95: Netherlands pharmaceuticals market value: $ billion, 2016-20

Table 96: Netherlands pharmaceuticals market geography segmentation: $ billion, 2020

Table 97: Netherlands pharmaceuticals market share: % share, by value, 2020

Table 98: Netherlands pharmaceuticals market value forecast: $ billion, 2020-25

Table 99: Netherlands size of population (million), 2016-20

Table 100: Netherlands gdp (constant 2005 prices, $ billion), 2016-20

Table 101: Netherlands gdp (current prices, $ billion), 2016-20

Table 102: Netherlands inflation, 2016-20

Table 103: Netherlands consumer price index (absolute), 2016-20

Table 104: Netherlands exchange rate, 2016-20

Table 105: Spain pharmaceuticals market value: $ billion, 2016-20

Table 106: Spain pharmaceuticals market geography segmentation: $ billion, 2020

Table 107: Spain pharmaceuticals market share: % share, by value, 2020

Table 108: Spain pharmaceuticals market value forecast: $ billion, 2020-25

Table 109: Spain size of population (million), 2016-20

Table 110: Spain gdp (constant 2005 prices, $ billion), 2016-20

Table 111: Spain gdp (current prices, $ billion), 2016-20

Table 112: Spain inflation, 2016-20

Table 113: Spain consumer price index (absolute), 2016-20

Table 114: Spain exchange rate, 2016-20

Table 115: United Kingdom pharmaceuticals market value: $ billion, 2016-20

Table 116: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2020

Table 117: United Kingdom pharmaceuticals market share: % share, by value, 2020

Table 118: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25

Table 119: United Kingdom size of population (million), 2016-20

Table 120: United Kingdom gdp (constant 2005 prices, $ billion), 2016-20

Table 121: United Kingdom gdp (current prices, $ billion), 2016-20

Table 122: United Kingdom inflation, 2016-20

Table 123: United Kingdom consumer price index (absolute), 2016-20

Table 124: United Kingdom exchange rate, 2016-20

Table 125: United States pharmaceuticals market value: $ billion, 2016-20

Table 126: United States pharmaceuticals market geography segmentation: $ billion, 2020

Table 127: United States pharmaceuticals market share: % share, by value, 2020

Table 128: United States pharmaceuticals market value forecast: $ billion, 2020-25

Table 129: United States size of population (million), 2016-20

Table 130: United States gdp (constant 2005 prices, $ billion), 2016-20

Table 131: United States gdp (current prices, $ billion), 2016-20

Table 132: United States inflation, 2016-20

Table 133: United States consumer price index (absolute), 2016-20

Table 134: United States exchange rate, 2016-20

Table 135: Sanofi SA: key facts

Table 136: Sanofi SA: Annual Financial Ratios

Table 137: Sanofi SA: Key Employees

Table 138: Sanofi SA: Key Employees Continued

Table 139: Laboratoires Pierre Fabre SA: key facts

Table 140: Laboratoires Pierre Fabre SA: Key Employees

Table 141: Les Laboratoires Servier: key facts

Table 142: Les Laboratoires Servier: Key Employees

Table 143: F. Hoffmann-La Roche Ltd: key facts

Table 144: F. Hoffmann-La Roche Ltd: Annual Financial Ratios

Table 145: F. Hoffmann-La Roche Ltd: Key Employees

Table 146: Bayer AG: key facts

Table 147: Bayer AG: Annual Financial Ratios

Table 148: Bayer AG: Key Employees

Table 149: Bayer AG: Key Employees Continued

Table 150: Boehringer Ingelheim GmbH: key facts

Table 151: Boehringer Ingelheim GmbH: Key Employees

Table 152: A Menarini Industrie Farmaceutiche Riunite Srl: key facts

Table 153: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees

Table 154: Recordati S.p.A.: key facts

Table 155: Recordati S.p.A.: Annual Financial Ratios

Table 156: Recordati S.p.A.: Key Employees

Table 157: Chiesi Farmaceutici SpA: key facts

Table 158: Chiesi Farmaceutici SpA: Key Employees

Table 159: Daiichi Sankyo Co Ltd: key facts

Table 160: Daiichi Sankyo Co Ltd: Annual Financial Ratios

Table 161: Daiichi Sankyo Co Ltd: Key Employees

Table 162: Daiichi Sankyo Co Ltd: Key Employees Continued

Table 163: Astellas Pharma Inc.: key facts

Table 164: Astellas Pharma Inc.: Annual Financial Ratios

Table 165: Astellas Pharma Inc.: Key Employees

Table 166: Astellas Pharma Inc.: Key Employees Continued

Table 167: Takeda Pharmaceutical Company Limited: key facts

Table 168: Takeda Pharmaceutical Company Limited: Annual Financial Ratios

Table 169: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)

Table 170: Takeda Pharmaceutical Company Limited: Key Employees

Table 171: Takeda Pharmaceutical Company Limited: Key Employees Continued

Table 172: Mitsubishi Tanabe Pharma Corporation: key facts

Table 173: Mitsubishi Tanabe Pharma Corporation: Key Employees

Table 174: Aspen Pharmacare Holdings Ltd: key facts

Table 175: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios

Table 176: Aspen Pharmacare Holdings Ltd: Key Employees

Table 177: Apotex, Inc.: key facts

Table 178: Apotex, Inc.: Key Employees

Table 179: Yangtze River Pharmaceutical Group: key facts

Table 180: Yangtze River Pharmaceutical Group: Key Employees

Table 181: Shanghai Pharmaceuticals Holding Co Ltd: key facts

Table 182: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios

Table 183: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees

Table 184: Yunnan Baiyao Group Co Ltd: key facts

Table 185: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios

Table 186: Yunnan Baiyao Group Co Ltd: Key Employees

Table 187: Guangzhou Pharmaceutical Holdings Ltd: key facts

Table 188: Guangzhou Pharmaceutical Holdings Ltd: Key Employees

Table 189: Almirall S.A.: key facts

Table 190: Almirall S.A.: Annual Financial Ratios

Table 191: Almirall S.A.: Key Employees

Table 192: Laboratorios Farmaceuticos ROVI, S.A.: key facts

Table 193: Laboratorios Farmaceuticos ROVI, S.A.: Annual Financial Ratios

Table 194: Laboratorios Farmaceuticos ROVI, S.A.: Key Employees

Table 195: Novartis AG: key facts

Table 196: Novartis AG: Annual Financial Ratios

Table 197: Novartis AG: Key Employees

Table 198: Novartis AG: Key Employees Continued

Table 199: GlaxoSmithKline Plc: key facts

Table 200: GlaxoSmithKline Plc: Annual Financial Ratios

Table 201: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)

Table 202: GlaxoSmithKline Plc: Key Employees

Table 203: GlaxoSmithKline Plc: Key Employees Continued

Table 204: Johnson & Johnson: key facts

Table 205: Johnson & Johnson: Annual Financial Ratios

Table 206: Johnson & Johnson: Key Employees

Table 207: Johnson & Johnson: Key Employees Continued

Table 208: Pfizer Inc.: key facts

Table 209: Pfizer Inc.: Annual Financial Ratios

Table 210: Pfizer Inc.: Annual Financial Ratios (Continued)

Table 211: Pfizer Inc.: Key Employees

Table 212: Pfizer Inc.: Key Employees Continued

Table 213: Merck & Co., Inc.: key facts

Table 214: Merck & Co., Inc.: Annual Financial Ratios

Table 215: Merck & Co., Inc.: Key Employees

Table 216: Merck & Co., Inc.: Key Employees Continued

Table 217: AstraZeneca PLC: key facts

Table 218: AstraZeneca PLC: Annual Financial Ratios

Table 219: AstraZeneca PLC: Key Employees

List of Figures

List of Figures

Figure 1: Global pharmaceuticals market value: $ billion, 2016-20

Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 3: Global pharmaceuticals market share: % share, by value, 2020

Figure 4: Global pharmaceuticals market value forecast: $ billion, 2020-25

Figure 5: Forces driving competition in the global pharmaceuticals market, 2020

Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2020

Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2020

Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2020

Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2020

Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2020

Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20

Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020

Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25

Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2020

Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2020

Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2020

Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2020

Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2020

Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2020

Figure 21: Europe pharmaceuticals market value: $ billion, 2016-20

Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 23: Europe pharmaceuticals market share: % share, by value, 2020

Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2020-25

Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2020

Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2020

Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2020

Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2020

Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2020

Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2020

Figure 31: France pharmaceuticals market value: $ billion, 2016-20

Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 33: France pharmaceuticals market share: % share, by value, 2020

Figure 34: France pharmaceuticals market value forecast: $ billion, 2020-25

Figure 35: Forces driving competition in the pharmaceuticals market in France, 2020

Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2020

Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2020

Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020

Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020

Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020

Figure 41: Germany pharmaceuticals market value: $ billion, 2016-20

Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 43: Germany pharmaceuticals market share: % share, by value, 2020

Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2020-25

Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2020

Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2020

Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2020

Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020

Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020

Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020

Figure 51: Italy pharmaceuticals market value: $ billion, 2016-20

Figure 52: Italy pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 53: Italy pharmaceuticals market share: % share, by value, 2020

Figure 54: Italy pharmaceuticals market value forecast: $ billion, 2020-25

Figure 55: Forces driving competition in the pharmaceuticals market in Italy, 2020

Figure 56: Drivers of buyer power in the pharmaceuticals market in Italy, 2020

Figure 57: Drivers of supplier power in the pharmaceuticals market in Italy, 2020

Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2020

Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2020

Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2020

Figure 61: Japan pharmaceuticals market value: $ billion, 2016-20

Figure 62: Japan pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 63: Japan pharmaceuticals market share: % share, by value, 2020

Figure 64: Japan pharmaceuticals market value forecast: $ billion, 2020-25

Figure 65: Forces driving competition in the pharmaceuticals market in Japan, 2020

Figure 66: Drivers of buyer power in the pharmaceuticals market in Japan, 2020

Figure 67: Drivers of supplier power in the pharmaceuticals market in Japan, 2020

Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2020

Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2020

Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2020

Figure 71: Australia pharmaceuticals market value: $ billion, 2016-20

Figure 72: Australia pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 73: Australia pharmaceuticals market share: % share, by value, 2020

Figure 74: Australia pharmaceuticals market value forecast: $ billion, 2020-25

Figure 75: Forces driving competition in the pharmaceuticals market in Australia, 2020

Figure 76: Drivers of buyer power in the pharmaceuticals market in Australia, 2020

Figure 77: Drivers of supplier power in the pharmaceuticals market in Australia, 2020

Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2020

Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2020

Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2020

Figure 81: Canada pharmaceuticals market value: $ billion, 2016-20

Figure 82: Canada pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 83: Canada pharmaceuticals market share: % share, by value, 2020

Figure 84: Canada pharmaceuticals market value forecast: $ billion, 2020-25

Figure 85: Forces driving competition in the pharmaceuticals market in Canada, 2020

Figure 86: Drivers of buyer power in the pharmaceuticals market in Canada, 2020

Figure 87: Drivers of supplier power in the pharmaceuticals market in Canada, 2020

Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020

Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020

Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020

Figure 91: China pharmaceuticals market value: $ billion, 2016-20

Figure 92: China pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 93: China pharmaceuticals market share: % share, by value, 2020

Figure 94: China pharmaceuticals market value forecast: $ billion, 2020-25

Figure 95: Forces driving competition in the pharmaceuticals market in China, 2020

Figure 96: Drivers of buyer power in the pharmaceuticals market in China, 2020

Figure 97: Drivers of supplier power in the pharmaceuticals market in China, 2020

Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2020

Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2020

Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in China, 2020

Figure 101: Netherlands pharmaceuticals market value: $ billion, 2016-20

Figure 102: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 103: Netherlands pharmaceuticals market share: % share, by value, 2020

Figure 104: Netherlands pharmaceuticals market value forecast: $ billion, 2020-25

Figure 105: Forces driving competition in the pharmaceuticals market in the Netherlands, 2020

Figure 106: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2020

Figure 107: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2020

Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2020

Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2020

Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2020

Figure 111: Spain pharmaceuticals market value: $ billion, 2016-20

Figure 112: Spain pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 113: Spain pharmaceuticals market share: % share, by value, 2020

Figure 114: Spain pharmaceuticals market value forecast: $ billion, 2020-25

Figure 115: Forces driving competition in the pharmaceuticals market in Spain, 2020

Figure 116: Drivers of buyer power in the pharmaceuticals market in Spain, 2020

Figure 117: Drivers of supplier power in the pharmaceuticals market in Spain, 2020

Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2020

Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2020

Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2020

Figure 121: United Kingdom pharmaceuticals market value: $ billion, 2016-20

Figure 122: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 123: United Kingdom pharmaceuticals market share: % share, by value, 2020

Figure 124: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25

Figure 125: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2020

Figure 126: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2020

Figure 127: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2020

Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2020

Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2020

Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2020

Figure 131: United States pharmaceuticals market value: $ billion, 2016-20

Figure 132: United States pharmaceuticals market geography segmentation: % share, by value, 2020

Figure 133: United States pharmaceuticals market share: % share, by value, 2020

Figure 134: United States pharmaceuticals market value forecast: $ billion, 2020-25

Figure 135: Forces driving competition in the pharmaceuticals market in the United States, 2020

Figure 136: Drivers of buyer power in the pharmaceuticals market in the United States, 2020

Figure 137: Drivers of supplier power in the pharmaceuticals market in the United States, 2020

Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2020

Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2020

Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2020

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports